Patent details
300371
Product Name:
Ranolazine of een zout of solvaat daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300371
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1109558
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300371
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/08/462/001-006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/07/2008
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
27/11/2008
First Marketing Authorization date:
14/07/2008
Grant date:
01/10/2009
Activation date:
09/09/2019
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/11/2008
SPC/SPC Extension Expiration Date:
13/07/2023
Lapsed By Expiration Date:
14/07/2023
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
15/10/2018
Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, 94404, Foster City, California, United States of America (US)
Historical Applicant/holder
From:
20/02/2009
To:
20/02/2009
Name:
CV THERAPEUTICS, INC.
Address:
3172 Porter Drive, 94304, Palo Alto, California, United States of America (US)
From:
20/02/2009
To:
15/10/2018
Name:
Roche Palo Alto LLC
Address:
3431 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)
From:
20/02/2009
To:
20/02/2009
Name:
Roche Palo Alto LLC
Address:
3431 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)
From:
27/11/2008
To:
20/02/2009
Name:
Syntex (U.S.A.) LLC
Address:
3401 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)
From:
27/11/2008
To:
20/02/2009
Name:
CV THERAPEUTICS, INC.
Address:
3172 Porter Drive, 94304, Palo Alto, California, United States of America (US)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
27/11/2008
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
29/23
Publication date:
19/07/2023
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
37/19
Publication date:
11/09/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
CO
Journal edition number:
52/18
Publication date:
19/12/2018
Description:
Changes in the Netherlands Patent Register
4
Bulletin Heading:
SPC
Journal edition number:
33/16
Publication date:
17/08/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
Bulletin Heading:
CO
Journal edition number:
2009/05
Publication date:
06/05/2009
Description:
Changes in the Netherlands Patent Register
6
Bulletin Heading:
MED
Journal edition number:
2009/05
Publication date:
06/05/2009
Description:
Other communications
7
Bulletin Heading:
SPC
Journal edition number:
2009/02
Publication date:
02/02/2009
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801819A
Date Registered:
15/10/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, 94404, Foster City, California, United States of America (US)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
53179-A053179-1
Date Registered:
20/02/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
53178-A053178-1
Date Registered:
20/02/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
23/08/2022
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date
Document type
Document Description
Number of pages
File Type
05/01/2016
SPC Documents
Certificate SPC
1
PDF
/1/7/3/0/0/0400300371/docs/300371_7_supplprotectioncertificate20210217052059762.pdf
05/01/2016
Outgoing Correspondence
Decision grant
1
PDF
/1/7/3/0/0/0400300371/docs/300371_11_outgoingcorrespondence20210217051827092.pdf
16/12/2015
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/1/7/3/0/0/0400300371/docs/300371_9_incomingcorrespondencepaper20210217051543130.pdf
16/12/2015
SPC Documents
Annex SPC
1
PDF
/1/7/3/0/0/0400300371/docs/300371_10_supplprotectioncertificate20210217051705607.pdf
01/10/2009
SPC Documents
Certificate SPC
1
PDF
/1/7/3/0/0/0400300371/docs/300371_3_supplprotectioncertificate20210217051157668.pdf
01/10/2009
Outgoing Correspondence
Outgoing Letter
1
PDF
/1/7/3/0/0/0400300371/docs/300371_14_outgoingcorrespondence20091001.pdf
17/09/2009
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/1/7/3/0/0/0400300371/docs/300371_8_incomingcorrespondencepaper20210217051042962.pdf
14/07/2009
Outgoing Correspondence
Outgoing Letter
2
PDF
/1/7/3/0/0/0400300371/docs/300371_1_outgoingcorrespondence20090714.pdf
13/07/2009
SPC Documents
Annex SPC
2
PDF
/1/7/3/0/0/0400300371/docs/300371_0_supplprotectioncertificate20210217050653025.pdf
13/07/2009
SPC Documents
Annex SPC
54
PDF
/1/7/3/0/0/0400300371/docs/300371_2_supplprotectioncertificate20210217050349326.pdf
17/12/2008
SPC Documents
Annex SPC
4
PDF
/1/7/3/0/0/0400300371/docs/300371_6_supplprotectioncertificate20210217045947194.pdf
02/12/2008
Outgoing Correspondence
Outgoing Letter
1
PDF
/1/7/3/0/0/0400300371/docs/300371_12_outgoingcorrespondence20081202.pdf
27/11/2008
SPC Documents
Summary of the characteristics of the product
35
PDF
/1/7/3/0/0/0400300371/docs/300371_5_supplprotectioncertificate20210217045732237.pdf
27/11/2008
Application Form
First filed application form
2
PDF
/1/7/3/0/0/0400300371/docs/300371_13_applicationform20081127.pdf
22/05/2002
SPC Documents
Annex SPC
17
PDF
/1/7/3/0/0/0400300371/docs/300371_4_supplprotectioncertificate20210217045302985.pdf